Dr. Jeff Cao completed his BSc Honours in Pharmacology and MD from the University of Alberta. During residency in Radiation Oncology at the University of Western Ontario, he earned his MBA at the Richard Ivey School of Business and honoured with the Health Sector Highest Contribution Award. Dr. Cao was the recipient of the OMA Resident Achievement Award upon return to residency and subsequently awarded the CARO Elekta Fellowship for research at the BC Cancer Agency in Vancouver and then received the inaugural CPQR Fellowship with the Canadian Partnership for Quality Radiotherapy. During Fellowship, Dr. Cao served on the CARO Board of Directors and conferred the CARO Extraordinary Contribution Award. He is immediate past Chair of the CARO Communications Committee and past Treasurer and current Chair of the Canadian Radiation Oncology Foundation. Dr. Cao is the former Lead Breast Radiation Oncologist at the Tom Baker Cancer Centre and currently the Alberta Health Services Provincial Breast Tumour Team Lead. His subspecialty focus in addition to Breast is Hematological Malignancies including Total Body Irradiation. Dr. Cao is Medical Lead for the Oncology Leadership and Development Office at the University of Calgary including the Physician Wellness portfolio as a Physician Collaborator with Well Doc Alberta. He is also past Treasurer and current President-Elect of the Alberta Medical Association Section of Radiation Oncology.
Cao, Jeffrey Q.
Radiation Oncology
Clinical Assistant Professor
Web Presence:
Twitter: @JeffCaoMDMBA
Biography
Area of Focus
Summary of Research
Key Publications:
Rakovitch et al. DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS. Breast Cancer Res Treat. 2021
Al-Rashdan et al. Adapting Radiation Therapy Treatments for Patients with Breast Cancer During the COVID-19 Pandemic: Hypo-Fractionation and Accelerated Partial Breast Irradiation to Address World Health Organization Recommendations. Adv Radiat Oncol. 2020
Cao JQ et al. Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort. Int J Radiat Oncol Biol Phys. 2014.
Cao JQ et al. Comparison of recurrence and survival rates after breast-conserving therapy and mastectomy in young women with breast cancer. Curr Oncol. 2013
Area Of Focus
Summary Of Research
Key Publications:
Rakovitch et al. DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS. Breast Cancer Res Treat. 2021
Al-Rashdan et al. Adapting Radiation Therapy Treatments for Patients with Breast Cancer During the COVID-19 Pandemic: Hypo-Fractionation and Accelerated Partial Breast Irradiation to Address World Health Organization Recommendations. Adv Radiat Oncol. 2020
Cao JQ et al. Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort. Int J Radiat Oncol Biol Phys. 2014.
Cao JQ et al. Comparison of recurrence and survival rates after breast-conserving therapy and mastectomy in young women with breast cancer. Curr Oncol. 2013